Blood-Clot Drug Buyers Seek Class Cert. In Antitrust Suit
Indirect purchasers of blood clot drug Lovenox and its generic version asked a Tennessee federal court for class certification in their suit alleging Momenta Pharmaceuticals Inc. and Sandoz Inc. conspired to...To view the full article, register now.
Already a subscriber? Click here to view full article